Company: INDP
Filing Date: 2025-03-13
Form Type: 10-K
Source: 0001493152-25-010136
Chunk: 176

Company: Indaptus Therapeutics, Inc.
Filing Date: 2025-03-13
Form: 10-K
Item: Item 1
Chunk 176
---
 (formatted as Inline XBRL and contained in Exhibits 101)

    *
    Filed herewith

    #
    Furnished herewith

    +
    Indicates management contract or compensatory plan.

    ++ 
    The schedules to the agreement
    have been omitted pursuant to Item 601(a)(5) of Regulation S-K. A copy of any omitted schedule will be furnished to the SEC upon
    request.

Item
16. Form 10-K Summary

None.

96

SIGNATURES

Pursuant
to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this Report
to be signed on its behalf by the undersigned, thereunto duly authorized.

    Indaptus Therapeutics, Inc.

    Date: March
    13, 2025
    By:
    /s/
    Jeffrey A. Meckler

    Jeffrey A. Meckler

    Chief Executive Officer

POWER
OF ATTORNEY

KNOW
ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below hereby constitutes and appoints Jeffrey Meckler and Nir
Sassi, and each of them acting individually, as his attorney-in-fact, each with full power of substitution, for him in any and all capacities,
to sign any and all amendments to this Report on Form 10-K, and to file the same, with exhibits thereto and other documents in connection
therewith, with the Securities and Exchange Commission, hereby ratifying and confirming our signatures as they may be signed by our said
attorney to any and all amendments to said Report.

Pursuant
to the requirements of the Securities Exchange Act of 1934, as amended, this Report has been signed below by the following persons on
behalf of the Registrant in the capacities and on the dates indicated.

    Name
     
    Title
     
    Date

    /s/
    Jeffrey A. Meckler
     
    Chief Executive Officer
    and Director
     
    March
    13, 2025
  
    Jeffrey
    A. Meckler
     
    (Principal Executive Officer)

    /s/
    Nir Sassi
     
    Chief Financial Officer
     
    March
    13, 2025
  
    Nir
    Sassi
     
    (Principal Financial and
    Accounting Officer)

    /s/